Bibliografía del artículo
1. Kiprov D. Experimental models of hypertension. Cor Vasa 22(1-2):116-128, 1980.
2. Sun ZJ, Zhang ZE. Historic perspectives and recent advances in major animal models of hypertension. Acta Pharmacol Sin 26(3):295-301, 2005.
3. Baños G, El Hafidi M. En: Hypertension New Research. Chapter 1: Models of Experimental Hypertension. Pp 1-46. Ed. E. F. Benhagen. Nova Science Publishers, Inc. 2005.
4. Orange SJ, Ledingham JM, Laverty R. Cardiovascular effects of chronic nitric oxide inhibition in genetically hypertensive rats. Clin Exper Pharmacol Physiol 27(7):488-493, 2000.
5. Hamlyn JM. Acquired and inherited forms of ouabain-induced hypertension: significance and relationship to other models. Clin Exper Hypertens 25:289-290, 2003.
6. Swei A, Lacy F, DeLano FA, Schmid-Schönbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension 30:1628-1633, 1997.
7. Kurtz TW, Morris RC. Hypertension in the recently weaned Dahl salt-sensitive rat despite a diet deficient in sodium chloride. Science 230:808-810, 1985.
8. Hirata Y, Tobian L, Simon G, Iwai J. Hypertension-producing factor in serum of hypertensive Dahl salt-sensitive rats. Hypertension 6:709-716, 1984.
9. Jain M, Liao R, Podesser BK, Ngoy S, Apstein CS, Eberli FR. Influence of gender in the response to hemodynamic overload after myocardial infarction. Am J Physiol 283:H2544-H2550, 2002.
10. Seki S, Nagai M, Takeda H y cols. Impaired Ca2+ handling in perfused hypertrophic hearts from Dahl salt-sensitive rats. Hypertens Res 26:643-653, 2003.
11. Manning RD, Meng S, Tian N. Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. Acta Physiol Scand 179:243-250, 2003.
12. Vokurkova M, Dobesová Z, Pechánová O, Kunes J, Zicha J. Erythrocyte ion transport and membrane lipid composition in young and adult rats with NO-deficient hypertension. Life Sci 73(13):1637-1644, 2003.
13. Majid DS, Kopkan L. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension. Clin Exp Pharmacol Physiol 34(9):946-952, 2007.
14. Stolba P, Dobesová Z, Husek P y cols. The hypertriglyceridemic rat as a genetic model of hypertension and diabetes. Life Sci 51(10):733-740, 1992.
15. Kunes J, Devynck MA, Zicha J. Chronic changes in plasma triglyceride levels do modify platelet membrane microviscosity in rats. Life Sci 67(8):959-967, 2000.
16. Heller J, Hellerová S, Dobesová Z. The Prague hypertensive rat: a new model of genetic hypertension. Clin Exp Hypertens 15(5):807-818, 1993.
17. Friedman J, Peleg E, Kagan T. Shnizer S, Rosenthal T. Oxidative stress in hypertensive, diabetic, and diabetic hypertensive rats. Am J Hypertens 16(12):1049-1052, 2003.
18. Younis F, Kariv N, Nachman R, Zangen S, Rosenthal T. Telmisartan in the treatment of Cohen-Rosenthal Diabetic Hypertensive rats: the benefit of PPAR-gamma agonism. Clin Exp Hypertens 29(6):419-426, 2007.
19. Ojeda NB, Grigore D, Yanes LL y cols. Testosterone contributes to marked elevations in mean arterial pressure in adult male intrauterine growth restricted offspring. Am J Physiol Regul Integr Comp Physiol 292(2):R758-763, 2007.
20. Ojeda NB, Grigore D, Robertson EB, Alexander BT. Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring. Hypertension 50(4):679-685, 2007.
21. Brown DM, Provoost AP, Daly MJ, Jacob HJ. Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nature Genet 12(1):44-51, 1996.
22. Koletsky S. Obese spontaneously hypertensive rats--a model for study of atherosclerosis. Exp Mol Pathol 19(1):53-60, 1973.
23. Phillips JK, Hopwood D, Loxley RA y cols. Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease. Kidney Blood Press Res 30(3):129-144, 2007.
24. Zhou X, Frohlich ED. Analogy of cardiac and renal complications in essential hypertension and aged SHR or L-NAME/SHR. Med Chem 3(1):61-65, 2007.
25. Polizio AH, Gorzalczany S, Taira C, Peña C.Aortic coarctation induces oxidative stress in rat tissues. Life Sci 79(6):596-600, 2006.
26. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59(3):251-287, 2007.
27. Park HW, Kim Y, Kim KH, Jeong HJ, Shin MH, Rozen S, Mauer M. Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats. J Renin Angiotensin Aldosterone Syst 8(3):110-117, 2007.
28. Takahashi T, Konta T, Takasaki S, Ichikawa K, Takeishi Y, Kubota I. An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy. Clin Exp Nephrol 11(3):202-208, 2007.
29. Welch WJ, Patel K, Modlinger P y cols. Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension. Am J Physiol Heart Circ Physiol 293(5):H2644-H2649, 2007.
30. Fink G, Li M, Lau Y, Osborn J, Watts S. Chronic activation of endothelin B receptors: new model of experimental hypertension. Hypertension 50(3):512-518, 2007.
31. Xue B, Johnson AK, Hay M.Sex differences in angiotensin II- induced hypertension. Braz J Med Biol Res 40(5):727-734, 2007.
32. Baños G, Carvajal K, Cardoso G, Zamora J, Franco M. Vascular reactivity and effect of serum in a rat model of hypertriglyceridemia and hypertension. Am J Hypertens 10:379-388, 1997.
33. El Hafidi M, Valdez R, Baños G. Possible relationship between altered fatty acid composition of serum, platelets and aorta and hypertension induced by sugar feeding in rats. Clin Exper Hypertens 22(1):99-108, 2000.
34. Nava P, Guarner V, Posadas R, Pérez I, Baños G. Insulin-induced endothelin release and vasoreactivity in hypertriglyceridemic and hypertensive rats. Am J Physiol 277:H399-H404, 1999.
35. Perez TI, El Hafidi M, Carvajal K, Baños G. Castration modifies aortic vasoreactivity and serum fatty acids in a sucrose-fed rat model of metabolic syndrome. Heart & Vessels 2008 (in press).
36. El Hafidi M, Baños G. In vivo plasma lipid oxidation in sugar-induced rat hypertriglyceridemia and hypertension. Hypertension 30(part 2):624-628, 1997.
37. Carvajal K, Baños G, Moreno Sánchez R. Impairment of glucose metabolism and energy transfer in the hypertriglyceridemic rat heart. Mol Cell Biochem 249:157-165, 2003.
38. Baños G, Medina Campos OE, Maldonado PD y cols. Antioxidant enzymes in hypertensive and hypertriglyceridemic rats. Effect of gender. Clin Exper Hypertens 1:45-56, 2005.
39. Baños G, Medina ON, Maldonado PD y cols. Activities of antioxidant enzymes in two stages of pathology development in sucrose-fed rats. Can J Physiol Pharmacol 83(3):278-286, 2005.
40. Cárdenas G, Torres JC, Zamora J, Baños G. Isolated heart function during ischemia and reperfusion in sucrose-fed rats. Effect of insulin infusion. Cardiovascular Pathology 14:256-264, 2005.
41. Cárdenas G, Torres JC, Zamora J, Pérez I, Baños G. Isolated heart function after ischemia and reperfusion in sucrose-fed rats. Influence of gender and treatment. Clin Exper Hypertens 28(2):85-107, 2006.
42. Rubio ME, Baños G, Díaz E, Guarner V. Effect of age on insulin-induced endothelin release and vasoreactivity in hypertriglyceridemic and hypertensive rats. Experimental Gerontology 41(3):282-288, 2006.
43. El Hafidi M, Pérez I, Carrillo S, Cardoso G, Zamora J, Baños G. Effect of sex hormones on non-esterified fatty acids, intra-abdominal fat accumulation, and hypertension induced by sucrose diet in male rats. Clin Exp Hypertens 28(8):669-681, 2006.
44. El Hafidi M, Pérez I, Zamora J, Soto V, Carvajal-Sandoval G, Baños G. Glycine intake decreases plasma free fatty acids, adipose cell size, and blood pressure in sucrose-fed rats. Am J Physiol Regul Integr Comp Physiol 287:R1387-R1393, 2004.
45. El Hafidi M, Pérez I, Baños G. Is glycine effective against elevated blood pressure? Curr Opin Clin Nutr Metab Care 9:26-31, 2006.
46. El Hafidi M, Pérez I, Carrillo S, Cardoso G, Zamora J, Baños G. Effect of sex hormones on non-esterified fatty acids, intra-abdominal fat accumulation and hypertension induced by sucrose diet in male rats. Clin Exper Hypertens 28:1-13, 2006.
47. Pérez Torres I, El Hafidi M, Zamora GJ, Infante O, Baños G. Modulation of aortic vascular reactivity by sex hormones in a male rat model of metabolic syndrome. Life Sci 80:2170-2180, 2007.
48. Pérez Torres I, El Hafidi M, Infante O, Baños G. Effects of sex hormone levels on aortic vascular reactivity and variables associated with the metabolic syndrome in sucrose-fed female rats. Can J Physiol Pharmacol 86(1-2):25-35, 2008.
49. Bull TM, Coldren CD, Geraci MW, Voelkel NF.Gene expression profiling in pulmonary hypertension. Proc Am Thorac Soc 4(1):117-120, 2007.
50. Sullivan CC, Du L, Chu D y cols. Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway.Proc Natl Acad Sci USA 100(21):12331-12336, 2003.
51. Chu D, Sullivan CC, Du L y cols. A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin. Ann Thorac Surg 77(2):449-456, 2004.
52. Kolettis T, Vlahos AP, Louka M y cols. Characterisation of a rat model of pulmonary arterial hypertension. Hellenic J Cardiol 48(4):206-210, 2007.
53. Cook S, Hugli O, Egli M y cols. Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension. Diabetes 53(8):2067-2072, 2004.
54. Qi NR, Wang J, Zidek V y cols. A new transgenic rat model of hepatic steatosis and the metabolic syndrome. Hypertension 45(5):1004-1011, 2005.
55. Hiraoka-Yamamoto J, Nara Y, Yasui N, Onobayashi Y, Tsuchikura S, Ikeda K. Establishment of a new animal model of metabolic syndrome: SHRSP fatty (fa/fa)rats. Clin Exp Pharmacol Physiol 31(1-2):107-109, 2004.
56. Howard LL, Patterson ME, Mullins JJ, Mitchell KD. Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats. Am J Physiol Renal Physiol 288(4):F810-F815, 2005.
57. Svenson KL, Bogue MA, Peters LL. Invited review: Identifying new mouse models of cardiovascular disease: a review of high-throughput screens of mutagenized and inbred strains. J Appl Physiol 94(4):1650-1659; discussion 1673, 2003.
58. Pravenec M, Kurtz TW. Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies. Hypertension 49(5):941-952, 2007.